AXA/2026/1Q activity indicators: Difference between revisions

* Gross written premiums & other revenues ({{footnote: |insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business). Other Revenues represent premiums and fees collected on activities other than insurance (i.e. banking, services, and asset management activities).)}} up '''+6%''' vs. 1Q25 to '''EUR 38.0bn''' ^{p. 1}

** Property & Casualty premiums up '''+4%''' to '''EUR 21.5bn''' ^{p. 1}

*** Retail premiums up '''+7%''' with '''+4%''' from price effect and '''+3%''' from volumes ^{p. 1}

*** Commercial premiums up '''+3%''' with equal contributions from price effect and volumes ^{p. 1}

** Life & Health premiums up '''+8%''' to '''EUR 16.5bn''' ^{p. 1}

*** Life premiums up '''+8%''' ^{p. 1}

*** Health premiums up '''+8%''' ^{p. 1}

* Life & Health NB CSM (pre-tax) (footnote: a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided.) up '''+4%''' ^{p. 1}

* Net flows (footnote: Life & Health net flows, PVEP, NB CSM, NBV, and NBV margin include Health business predominantly written in Life entities.) of '''EUR +2.7bn''' ^{p. 1}

* Solvency II ratio (footnote: estimated primarily using AXA's internal model calibrated based on an adverse 1/200 years shock. It includes a theoretical amount for dividends and share buybacks accrued for the first three months of 2026, based on the full-year dividend of Euro 2.32 per share to be paid in 2026 for FY25 and annual share buyback of Euro 1.25 billion announced on February 26, 2026. Annual share buybacks exclude anti-dilutive share buybacks related to certain disposals and in-force management transactions, as well as share buybacks to offset dilutive effects relating to employee share offerings and stockbased compensation. Dividends and share buybacks are proposed by the Board, at its discretion based on a variety of factors described in AXA's 2025 Universal Registration Document and then submitted to AXA's shareholders for approval. This estimate should not be considered in any way to be an indication of the actual dividend and share buyback amounts, if any, for the 2026 financial year. For further information on AXA's internal model and Solvency II disclosures, please refer to AXA Group's Solvency and Financial Condition Report (SFCR) as of December 31, 2024, available on AXA's website (www.axa.com).) at '''211%''' as of March 31, 2026, down '''-4 points''' vs. January 1, 2026 (post-grandfathering period), reflecting resilience in a volatile environment ^{p. 1}